
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2018
Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
Journal: Leukemia research
Published: September 27, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026